Search Results - "Ormanns, S"

Alterations in regulatory T cells and immune checkpoint molecules in pancreatic cancer patients receiving FOLFIRINOX or gemcitabine plus nab-paclitaxel by Sams, L., Kruger, S., Heinemann, V., Bararia, D., Haebe, S., Alig, S., Haas, M., Zhang, D., Westphalen, C. B., Ormanns, S., Metzger, P., Werner, J., Weigert, O., von Bergwelt-Baildon, M., Rataj, F., Kobold, S., Boeck, S.

“…Purpose This pilot study aimed on generating insight on alterations in circulating immune cells during the use of FOLFIRINOX and gemcitabine/nab-paclitaxel in…”
Get full text

Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult by Boeck, S, Haas, M, Ormanns, S, Kruger, S, Siveke, J T, Heinemann, V

Get full text

Mismatch-repair-deficient metastatic pancreatic ductal adenocarcinoma with a germline PALB2 mutation: unusual genetics, unusual clinical course by Boeck, S., Mehraein, Y., Ormanns, S., Kruger, S., Westphalen, C.Benedikt, Haas, M., Jung, A., Kirchner, T., Heinemann, V.

Get full text

Comparison of 19G vs 22G Fransen EUS-FNB device for patient derived organoid (PDO) yield from primary pancreatic cancer: A prospective controlled study by Allawadhi, P., Xue, Y., Alnashta, A., Mahajan, U.M., Goni, E., Köpke, M., Sirtl, S., Klauss, S., Schulz, C., Schirra, J., Ormanns, S., Reichert, M., Mayerle, J., Beyer, G.

Get full text

Repeated mutKRAS ctDNA measurements in patients with advanced pancreatic cancer patients: Kinetics, response prediction and therapy monitoring in comparison to protein-based tumor markers by Kruger, S., Heinemann, V., Ross, C., Diehl, F., Ormanns, S., Liebmann, S., Westphalen, C.B., Haas, M., Jung, A., Kirchner, T., von Bergwelt-Baildon, M., Holdenrieder, S., Boeck, S.

Get full text

Alterations in peripheral T cell subsets, T cell activation markers and immune checkpoint molecules in advanced pancreatic cancer patients receiving FOLFIRINOX or gemcitabine + nab-paclitaxel by Sams, L.E., Kruger, S., Heinemann, V., Bararia, D., Haebe, S., Alig, S., Westphalen, B., Haas, M., Kirchner, T., Ormanns, S., Endres, S., Weigert, O., von Bergwelt-Baildon, M., Kobold, S., Rataj, F., Boeck, S.

Get full text

03.03 Tertiary lymphoid structures in pancreatic cancer resemble lymphoid follicles in secondary lymphoid organs as sites for initiation and maintenance of anti-tumor T- and B-cell responses by Wennhold, K, Lehmann, J, Thelen, M, Kreer, C, Garcia-Marquez, M, Lohneis, P, Boeck, S, Kruger, S, Ormanns, S, Rudelius, M, Werner, J, Popp, F, Klein, F, von Bergwelt-Baildon, M, Bruns, C, Quaas, A, Schlößer, HA

“…BackgroundTertiary lymphoid structures (TLS) have been described in close proximity to tumor areas in a variety of cancer types. Abundance of TLS is related to…”
Get full text

Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers: pooled data from three independent cohorts by Westphalen, C. B., Preinfalk, A., Kruger, S., Haas, M., Renz, B. W., Riener, M.-O., Weber, A., Kirchner, T., Werner, J., Heinemann, V., von Bergwelt-Baildon, M., Baba, H. A., Siveke, J. T., Ormanns, S., Boeck, S.

“…Background Neuronal signaling has been implicated in the pathophysiology of multiple malignancies. In biliary tract cancers (BTCs), tumor cell expression of…”
Get full text

Prognosis and tumor biology of pancreatic cancer patients with isolated lung metastases: translational results from the German multicenter AIO-YMO-PAK-0515 study by Kruger, S.F., Lohneis, A., Abendroth, A., Berger, A.W., Ettrich, T.J., Waidmann, O., Kapp, M., Steiner, B., Kumbrink, J., Reischer, A., Haas, M., Westphalen, C.B., Zhang, D., Miller-Phillips, L., Burger, P.J., Kobold, S., Werner, J., Subklewe, M., von Bergwelt-Baildon, M., Kunzmann, V., Seufferlein, T., Siveke, J.T., Sinn, M., Heinemann, V., Ormanns, S., Boeck, S.

“…Pulmonary metastasis (M1-PUL) as first site of dissemination in pancreatic ductal adenocarcinoma (PDAC) is a rare event and may define a distinct biological…”
Get full text

Neuroinfectious diseases at a European neurological tertiary care center: one-third of patients require treatment in the neurological intensive care unit by Buchholz, G., Ormanns, S., Pfister, H.-W., Koedel, U., Klein, M.

“…Background and purpose Studies on the impact of infectious diseases affecting the nervous system are sparse. Methods All patients with neuroinfectious diseases…”
Get full text

477 pERK Expression in Erlotinib-treated Patients with Advanced Pancreatic Cancer: a Translational Subgroup Analysis From the Randomized AIO-PK0104 Phase III Trial by Boeck, S, Ormanns, S, Laubender, R.P, Jung, A, Siveke, J.T, Haas, M, Kirchner, T, Heinemann, V

Get full text

Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer by Kruger, S., Heinemann, V., Ross, C., Diehl, F., Nagel, D., Ormanns, S., Liebmann, S., Prinz-Bravin, I., Westphalen, C.B., Haas, M., Jung, A., Kirchner, T., von Bergwelt-Baildon, M., Boeck, S., Holdenrieder, S.

“…The presence of mutated KRAS (mutKRAS ctDNA) in plasma samples has been consistently shown to be a negative prognostic indicator in pancreatic cancer (PC)…”
Get full text

Extramedullary multiple myeloma presenting as a pituitary mass lesion by Dimopoulou, C, Ormanns, S, Eigenbrod, S, Müller-Lisse, U, Emmerich, B, Reincke, M

“…A plasmocytoma involving the pituitary gland is an extremely rare entity, with approximately 22 cases of solitary myeloma or multiple myeloma presenting with…”
Get more information

Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair by Ferraro, Bartolo, Leoni, Giovanna, Hinkel, Rabea, Ormanns, Steffen, Paulin, Nicole, Ortega-Gomez, Almudena, Viola, Joana R, de Jong, Renske, Bongiovanni, Dario, Bozoglu, Tarik, Maas, Sanne L, D'Amico, Michele, Kessler, Thorsten, Zeller, Tanja, Hristov, Michael, Reutelingsperger, Chris, Sager, Hendrik B, Döring, Yvonne, Nahrendorf, Matthias, Kupatt, Christian, Soehnlein, Oliver

“…Heart failure following myocardial infarction (MI) remains one of the major causes of death worldwide, and its treatment is a crucial challenge of…”
Get full text

Arming T cells with C-X-C-motive receptor 6 enhances infiltration of pancreatic cancer patient-derived organoids by Ogonek, J., Lutz, J., Dantes, Z., Lesch, S., Stoiber, S., Schuebel, M., Voelkl, L., Ormanns, S., Reichert, M., Endres, S., Kobold, S.

Get full text

Expression of Indoleamine 2,3-dioxygenase in erlotinib-treated patients with advanced pancreatic cancer: Translational results from a multi-center, randomized phase III trial by Kruger, S., Ormanns, S., Roesgen, V., Legenstein, M., Haas, M., Westphalen, C.B., Duewell, P., Schnurr, M., Kirchner, T., von Bergwelt-Baildon, M., Heinemann, V., Boeck, S.

Get full text

714PRepeated mutKRAS ctDNA measurements in patients with advanced pancreatic cancer patients: Kinetics, response prediction and therapy monitoring in comparison to protein-based tumor markers by Kruger, S, Heinemann, V, Ross, C, Diehl, F, Ormanns, S, Liebmann, S, Westphalen, C B, Haas, M, Jung, A, Kirchner, T, von Bergwelt-Baildon, M, Holdenrieder, S, Boeck, S

Get full text

1195PAlterations in peripheral T cell subsets, T cell activation markers and immune checkpoint molecules in advanced pancreatic cancer patients receiving FOLFIRINOX or gemcitabine + nab-paclitaxel by Sams, L E, Kruger, S, Heinemann, V, Bararia, D, Haebe, S, Alig, S, Westphalen, B, Haas, M, Kirchner, T, Ormanns, S, Endres, S, Weigert, O, von Bergwelt-Baildon, M, Kobold, S, Rataj, F, Boeck, S

Get full text

Arming T cells with C-X-C-motive receptor 6 enables adoptive T cell therapy of pancreatic cancer by Lesch, S., Blumenberg, V., Stoiber, S., Ogonek, J., Cadilha, B., Dantes, Z., Rataj, F., Dorman, K., Lutz, J., Karches, C., Heise, C., Grassmann, S., Megens, R., Ruehland, S., Di Pilato, M., Pruessmann, J., Ormanns, S., Reischer, A., Duewell, P., Schnurr, M., Subklewe, M., Reichert, M., Mempel, T., Endres, S., Kobold, S.

Get full text

High infiltration of CD3+ and CD8+ T-Lymphocytes correlates with improved survival in pancreatic cancer by Miksch, R.C., Schoenberg, M.B.H., Weniger, M., Hao, J., Yin, S., Schiergens, T.S., Bächmann, S., Ormanns, S., Mayer, B., Bazhin, A.V., Werner, J., D'Haese, J.G.

Get full text